Central Admixture Pharmacy Services (CAPS), a B. Braun Group company, operates 503A regional pharmacies and 503B outsourcing facilities providing compounded sterile preparations and sterile admixture products. Its offerings include patient-specific parenteral nutrition, cardioplegia, standardized drug delivery products, pre-filled anesthesia syringes, and related compounding, testing, consulting, and training services.
FDA-registered 503B Outsourcing Facilities
Registration
Test, Hold and Release (THR)
Compliance program
CAPS Compliance Program
Compliance program
FDA503B
Quality certification